Broclear Tablet is used in the treatment of asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and cystic fibrosis. Discover Broclear Tablet’s uses, composition, dosage, side effects, precautions, interactions, and expert advice.
🟢 Broclear Tablet – Breathe easier with this trusted respiratory care tablet.
💊 Type: Prescription Medicine
🏢 Manufacturer: Intas Pharmaceuticals Ltd
🧪 Composition: Acebrophylline (100mg) + Acetylcysteine (600mg)
🌡️ Storage: Store below 30°C in a cool, dry place
🔁 Similar Medicines: [Click here to view substitutes]
Broclear Tablet is a combination medication containing two active ingredients: Acebrophylline (100mg) and Acetylcysteine (600mg). This dual-action formulation is designed to effectively manage various respiratory conditions, particularly those characterized by excessive and thick mucus production that can obstruct airways and impair breathing.
Acebrophylline is a derivative of theophylline and belongs to the xanthine family of bronchodilators. It works by relaxing the muscles in the airways, improving airflow, and enhancing mucociliary clearance. Acetylcysteine, on the other hand, is a powerful mucolytic agent that breaks down the disulfide bonds in mucus proteins, making phlegm less viscous and easier to cough up. Together, these two components create a synergistic effect that both widens the airways and thins the mucus, facilitating easier breathing and expectoration.
Broclear is primarily prescribed for conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, bronchial asthma, bronchiectasis, and other respiratory disorders where airway obstruction and mucus accumulation are significant factors. The combination of bronchodilation and mucolytic action makes it particularly valuable for patients who struggle with both airway constriction and difficulty in clearing secretions.
This medication represents an important therapeutic option in the management of chronic respiratory conditions, improving both short-term symptoms and potentially preventing long-term complications associated with persistent mucus retention and recurrent infections.
Active Ingredients:
Acebrophylline (100mg): A xanthine derivative with bronchodilator and anti-inflammatory properties
Acetylcysteine (600mg): A mucolytic agent that breaks down mucus and has antioxidant properties
Inactive Ingredients:
Microcrystalline cellulose
Lactose monohydrate
Povidone
Croscarmellose sodium
Magnesium stearate
Hypromellose
Titanium dioxide
Polyethylene glycol
Other pharmaceutical excipients for tablet formulation
Broclear Tablet is prescribed for the management of various respiratory conditions, including:
Chronic Obstructive Pulmonary Disease (COPD):
Helps reduce exacerbations
Improves airflow
Facilitates expectoration of viscous secretions
Aids in symptom management
Chronic Bronchitis:
Reduces frequency and severity of productive cough
Helps clear accumulated secretions
May reduce frequency of infections
Bronchial Asthma:
As adjunctive therapy in cases with mucus plugging
Helps in clearing airway secretions
May improve response to other asthma medications
Bronchiectasis:
Facilitates clearance of retained secretions
Helps manage chronic productive cough
May reduce frequency of respiratory infections
Acute Bronchitis:
Assists in recovery by promoting mucus clearance
Reduces coughing effort required to clear secretions
Other Respiratory Conditions:
Cystic fibrosis (as an adjunctive therapy)
Post-operative pulmonary complications
Atelectasis (lung collapse) due to mucus plugging
Pneumonia recovery phase
Preventive Use:
May be used to prevent exacerbations in chronic respiratory conditions
Seasonal use in patients prone to winter bronchitis
Perioperative use in patients with pulmonary risk factors
The combination of Acebrophylline and Acetylcysteine in Broclear Tablet offers multiple therapeutic benefits:
Dual Mechanism of Action:
Bronchodilation: Opens constricted airways
Mucolysis: Thins and breaks down thick mucus
Combined effect greater than either agent alone
Improved Respiratory Function:
Enhanced airflow through bronchial tubes
Increased forced expiratory volume (FEV1)
Improved vital capacity
Better oxygen exchange
Enhanced Mucus Clearance:
Reduced viscosity of bronchial secretions
Improved mucociliary clearance
Easier expectoration of phlegm
Prevention of mucus plugging
Anti-inflammatory Effects:
Reduces bronchial inflammation
Decreases airway hyperresponsiveness
May reduce structural changes in chronic conditions
Antioxidant Properties:
Acetylcysteine acts as a free radical scavenger
May protect lung tissue from oxidative damage
Potential to reduce inflammatory cascade
Reduced Exacerbation Frequency:
Fewer acute flare-ups of chronic conditions
Decreased need for emergency interventions
Reduced hospitalization rates in some patient groups
Quality of Life Improvements:
Reduced coughing effort
Decreased breathlessness
Improved exercise tolerance
Better sleep quality
Enhanced overall respiratory comfort
Convenient Combination:
Single tablet delivering dual therapeutic effects
Simplifies treatment regimen
May improve medication adherence
Broclear Tablet works through the complementary mechanisms of its two active components:
Bronchodilation:
Inhibits phosphodiesterase enzymes, particularly PDE3 and PDE4
Increases intracellular cyclic adenosine monophosphate (cAMP)
Results in relaxation of bronchial smooth muscle
Reduces airway resistance and improves airflow
Anti-inflammatory Effects:
Reduces the release of inflammatory mediators
Decreases neutrophil and eosinophil activity in lung tissue
Inhibits certain pro-inflammatory cytokines
Diminishes bronchial hyperresponsiveness
Mucoregulatory Activity:
Enhances mucociliary clearance
Stimulates production of surfactant by type II pneumocytes
Improves the rheological properties of mucus
Facilitates expectoration
Pulmonary Microcirculation:
May improve blood flow in pulmonary capillaries
Enhances oxygen delivery to respiratory tissues
Reduces pulmonary congestion
Mucolytic Action:
Contains a free thiol (-SH) group that breaks disulfide bonds (S-S) in mucus glycoproteins
Reduces the viscosity and elasticity of mucus
Transforms thick, sticky secretions into thinner, more fluid material
Facilitates removal through normal ciliary action and coughing
Antioxidant Properties:
Acts as a direct scavenger of free radicals, particularly reactive oxygen species
Replenishes glutathione, a major antioxidant in lung tissue
Protects cells from oxidative damage
Interrupts inflammatory cascades triggered by oxidative stress
Anti-inflammatory Effects:
Reduces neutrophil chemotaxis and activation
Decreases pro-inflammatory cytokine production
Inhibits nuclear factor-kappa B (NF-κB) activation
May decrease mucin production in airways
Biofilm Disruption:
Can disrupt bacterial biofilms in the respiratory tract
May enhance antibiotic penetration in respiratory infections
Potentially reduces bacterial colonization
The combination of these two agents provides synergistic benefits:
While Acebrophylline opens the airways, Acetylcysteine makes the mucus easier to clear
The bronchodilator effect enhances the distribution of the mucolytic agent
The mucolytic action improves the effectiveness of bronchodilation by clearing obstructing secretions
Combined anti-inflammatory and antioxidant effects may protect lung tissue more effectively than either agent alone
The typical recommended dosage for adults is:
For Chronic Respiratory Conditions:
One tablet once or twice daily, depending on severity of symptoms
Common regimen is one tablet in the morning and one in the evening
For Acute Exacerbations:
One tablet twice daily until symptoms improve
May be adjusted to one tablet three times daily in severe cases (physician discretion)
Usually reduced to maintenance dose after acute symptoms resolve
For Maintenance Therapy:
One tablet daily, typically in the morning
Duration depends on the underlying condition and clinical response
May be used for extended periods in chronic conditions
For Elderly Patients:
Usually start with one tablet daily
Dose may be adjusted based on tolerance and response
Pediatric Use:
Not recommended for children under 12 years
For adolescents (12-18 years): Dosage should be determined by a physician
Renal Impairment:
Mild to moderate: No specific dose adjustment necessary but monitor closely
Severe: Use with caution, consider dose reduction or increased interval
Hepatic Impairment:
Mild to moderate: No specific dose adjustment necessary
Severe: Consider dose reduction and monitor liver function
If a dose is missed:
Take it as soon as remembered if it's within a few hours of the scheduled time
If it's almost time for the next dose, skip the missed dose
Do not double the dose to make up for a missed dose
Return to the regular dosing schedule
Symptoms of overdose may include:
Nausea, vomiting, epigastric pain
Tachycardia, palpitations, or heart rhythm disturbances
Headache, dizziness, insomnia
Tremors or seizures (in severe cases)
Hypotension or hypertension
If overdose is suspected, seek medical attention immediately.
Take Broclear Tablet exactly as prescribed by your healthcare provider
Swallow the tablet whole with a full glass of water (approximately 240 ml)
The tablet can be taken with or without food, though taking with food may reduce stomach upset
If stomach irritation occurs, take with meals or immediately after eating
Take at approximately the same time(s) each day to maintain consistent blood levels
Do not crush, chew, or break the tablet as this may affect the release of the medication
Stay well-hydrated while taking this medication to help thin mucus further
If prescribed as "when needed," use at the first signs of mucus accumulation
For best results in chronic conditions, take regularly even if symptoms improve
Maintain airway clearance techniques (if recommended) such as controlled coughing or chest physiotherapy
Gastrointestinal Effects:
Nausea or upset stomach
Heartburn or indigestion
Mild abdominal discomfort
Diarrhea
Nervous System Effects:
Mild headache
Dizziness
Slight tremors
Other Common Effects:
Unpleasant taste in mouth (especially from Acetylcysteine)
Facial flushing
Palpitations
Rash or itching
Slight increase in heart rate
These side effects often resolve as your body adjusts to the medication.
Insomnia or sleep disturbances
Anxiety or nervousness
Muscle cramps
Tinnitus (ringing in the ears)
Dry mouth
Increased sweating
Changes in blood pressure
Bronchospasm (paradoxical reaction, more common in asthmatic patients)
Severe allergic reactions (anaphylaxis)
Severe skin reactions (Stevens-Johnson syndrome, very rare)
Significant cardiac rhythm disturbances
Seizures
Gastrointestinal bleeding
Severe liver function abnormalities
Significant changes in blood counts
For gastrointestinal issues: Take with food or milk
For headache: OTC pain relievers may help (consult doctor first)
For taste issues: Drinking juice after taking medication may help
For dizziness: Change positions slowly, avoid driving if affected
Report any persistent or severe side effects to your healthcare provider immediately
Moderate Caution: Alcohol may increase the risk of stomach irritation
May enhance dizziness or drowsiness side effects
May reduce the effectiveness of the medication
Best to limit or avoid alcohol while taking this medication
Category C: Potential risks to the fetus; benefits may outweigh risks in certain situations
Not enough well-controlled studies in pregnant women
Use only if clearly needed and after discussion with an obstetrician
Alternative medications may be considered for respiratory symptoms during pregnancy
Both active ingredients may pass into breast milk
Limited data on safety during lactation
Potential for side effects in nursing infants
Discuss risks and benefits with healthcare provider
Consider temporary interruption of breastfeeding or alternative medications
May cause dizziness, headache, or tremors in some patients
Avoid driving or operating hazardous machinery until you know how the medication affects you
Take particular caution during the first few days of treatment
Acetylcysteine is generally safe in patients with kidney impairment
Dose adjustment usually not required for mild to moderate kidney impairment
In severe kidney disease, monitor renal function and consider dose reduction
Report any changes in urination patterns or fluid retention
Both components are metabolized in the liver
Use with caution in patients with pre-existing liver disease
Regular liver function tests may be recommended during long-term therapy
Discontinue if signs of liver injury develop (jaundice, dark urine, right upper abdominal pain)
Safety and efficacy not fully established for children under 12 years
Should only be used in pediatric patients when clearly needed
Dosage must be determined by a pediatric specialist
Monitor children closely for side effects
Generally well-tolerated but may be more sensitive to side effects
Start with lower doses and titrate carefully
Monitor for dehydration, especially with increased expectoration
Greater risk of drug interactions due to polypharmacy common in elderly
Contraindicated in patients with known hypersensitivity to either component
Those with asthma or bronchospasm may be at higher risk of hypersensitivity reactions
Acetylcysteine has a distinctive odor that some may find unpleasant, but this is not an allergic reaction
Asthma and Bronchospasm:
Use with caution in patients with asthma
Bronchospasm can occur, especially in those with hyperreactive airways
Initial doses should be monitored in asthmatic patients
Have bronchodilator rescue medication available
Peptic Ulcer Disease:
Use with caution in patients with active or history of peptic ulcers
May exacerbate gastrointestinal irritation
Consider protective co-medication in high-risk patients
Cardiac Conditions:
Use with caution in patients with cardiac arrhythmias, coronary artery disease, or hypertension
Xanthine derivatives can cause tachycardia and palpitations
Monitor cardiac function in high-risk patients
Increased Secretions:
Initially, patients may experience increased volume of secretions
Ensure adequate clearance ability, especially in debilitated patients
May require temporary assistance with airway clearance
Dehydration Risk:
Maintain adequate hydration while taking this medication
Particularly important in elderly patients or during acute illness
Adequate fluid intake enhances the mucolytic effect
Elderly Patients:
May be more sensitive to side effects
Monitor for adverse reactions more closely
Consider starting with lower doses
Renal or Hepatic Impairment:
Use with caution in severe disease
May require dose adjustment or increased monitoring
Discontinue if evidence of worsening function
Drug Interactions:
Multiple potential interactions (see Interactions section)
Review all current medications before starting
Inform all healthcare providers about this medication
Paradoxical Bronchospasm:
If bronchospasm occurs after administration, discontinue and seek medical attention
More common in patients with hyperreactive airways
Have rescue medication available, especially when starting therapy
Long-term Use:
Periodic assessment of continued need for therapy
Monitor for side effects with extended use
Regular follow-up with healthcare provider recommended
Acebrophylline Interactions:
Other Xanthines:
Theophylline, aminophylline, caffeine
Increased risk of xanthine-related side effects
Avoid concurrent use when possible
Beta-Blockers:
May counteract the bronchodilating effects of Acebrophylline
Cardioselective beta-blockers have less interaction
Monitor for reduced efficacy
Certain Antibiotics:
Erythromycin, ciprofloxacin, clarithromycin
May increase Acebrophylline levels
Monitor for increased side effects
Cimetidine:
Decreases clearance of xanthines
May increase drug levels and side effects
Consider alternative H2 antagonists if needed
Acetylcysteine Interactions:
Antibiotics:
May reduce absorption of some antibiotics (especially penicillins, tetracyclines)
Administer antibiotics at least 2 hours before or after Broclear
Monitor for reduced antibiotic efficacy
Nitroglycerin:
Acetylcysteine may enhance vasodilatory effects
Monitor for increased hypotensive response
Dose adjustments may be necessary
Activated Charcoal:
Reduces effectiveness of Acetylcysteine
Avoid concurrent administration
Separate doses by at least 2 hours
Carbamazepine:
Acetylcysteine may reduce carbamazepine levels
Monitor for decreased seizure control
May require carbamazepine dose adjustment
Other Significant Interactions:
Corticosteroids:
Concurrent use generally beneficial in respiratory conditions
May enhance efficacy without significant interaction
Blood Pressure Medications:
Monitor blood pressure when starting Broclear
Adjust antihypertensive medications if needed
Insulin/Antidiabetic Drugs:
Xanthines may affect glucose metabolism
Monitor blood glucose more frequently when starting therapy
Food in General:
Taking with food may reduce gastrointestinal side effects
High-fat meals might slightly delay absorption but not significantly affect overall bioavailability
Consistent timing with respect to meals is recommended
Caffeine:
Found in coffee, tea, energy drinks, some sodas, and chocolate
Additive effects with the xanthine component
May increase risk of side effects like nervousness, insomnia, and palpitations
Moderate caffeine consumption advised during treatment
Dairy Products:
May slightly reduce absorption of Acetylcysteine component
Not usually clinically significant
If concerned, can separate dairy consumption by 1-2 hours
Broclear Tablet is absolutely contraindicated in patients with:
Hypersensitivity to Acebrophylline, Acetylcysteine, or any component of the formulation
Active peptic ulcer disease
Severe liver impairment
History of seizure disorders
Severe uncontrolled cardiac arrhythmias
Recent myocardial infarction
Pregnancy (first trimester)
Children under 12 years of age (unless specifically prescribed by a specialist)
Severe renal impairment (eGFR <30 ml/min)
Severe bronchial asthma with history of bronchospasm with mucolytics
FDA Pregnancy Category: C (Risk cannot be ruled out)
Risk-Benefit Assessment: Use only when potential benefits justify potential risks
Monitoring Requirements:
Regular assessment of respiratory function
Periodic liver function tests with long-term use
Monitoring of cardiac parameters in those with heart conditions
Assessment of mucus production and clearance
Hydration Recommendations:
Drink 2-3 liters of water daily unless contraindicated
Adequate hydration enhances mucolytic effects
Warm liquids may further help loosen secretions
Avoid excessive dairy products which may thicken mucus in some individuals
Dietary Considerations:
Limit caffeine intake (coffee, tea, energy drinks)
Consider reducing dairy consumption if it seems to increase mucus production
Include fruits and vegetables rich in antioxidants
Avoid known respiratory irritants in food (if identified)
Lifestyle Modifications:
Stop smoking and avoid second-hand smoke
Use air purifiers in the home if possible
Maintain optimal humidity levels (40-50%)
Regular moderate exercise as tolerated to improve lung function
Avoid exposure to air pollution when possible
Practice good sleep hygiene for adequate rest
Airway Clearance Techniques:
Learn and practice effective coughing techniques
Consider postural drainage positions if recommended
Deep breathing exercises can help mobilize secretions
Physical activity helps promote natural clearance mechanisms
Environmental Considerations:
Minimize exposure to allergens if allergic
Wear a mask in very cold weather or polluted environments
Keep indoor air clean and well-ventilated
Avoid strong fumes from cleaning products, paints, etc.
Physicians prescribe Broclear Tablet for several key reasons:
Dual Mechanism Advantage:
Combines bronchodilation and mucolytic effects
Addresses both airway constriction and mucus hypersecretion
More comprehensive than single-agent therapy
Improved Expectoration:
Facilitates clearance of obstructing secretions
Reduces the effort required to cough up phlegm
Helps break the cycle of mucus retention and infection
Enhanced Respiratory Function:
Improves lung function parameters
Reduces feelings of breathlessness
Enhances oxygen exchange
Exacerbation Prevention:
May reduce frequency of acute flare-ups
Decreases need for additional medications
Potentially reduces hospitalization rates
Convenience of Combination:
Single tablet rather than multiple medications
Improves adherence to treatment regimen
Simplified dosing schedule
Additional Benefits:
Anti-inflammatory and antioxidant properties
Potential protective effects on lung tissue
May improve quality of life measurements
Similar Combinations:
Ambrodil-S (Ambroxol + Salbutamol)
Mucolite-LS (Levosalbutamol + Ambroxol)
Ascoril (Salbutamol + Bromhexine + Guaiphenesin)
Mucobrom (Terbutaline + Bromhexine)
Alternative Combinations:
Bronchodilator + Inhaled Corticosteroid combinations
Bronchodilator + Anticholinergic combinations
Expectorant + Antihistamine combinations (for certain conditions)
For Bronchodilator Effect:
Theophylline
Doxofylline
Beta-2 agonists (Salbutamol, Formoterol)
Anticholinergics (Tiotropium, Ipratropium)
For Mucolytic Effect:
Ambroxol
Bromhexine
Erdosteine
Carbocisteine
Guaifenesin
Other Respiratory Medications:
Inhaled corticosteroids (for inflammatory component)
Leukotriene modifiers (for certain asthmatic conditions)
Phosphodiesterase-4 inhibitors (for COPD)
Note: Substitution should only be done under medical supervision as different medications have different properties, side effects, and contraindications.
Store at room temperature (15-30°C or 59-86°F)
Keep away from direct sunlight and moisture
Store in the original container with the lid tightly closed
Keep out of reach of children
Do not store in the bathroom or near the kitchen sink
Do not refrigerate or freeze
Check the expiration date regularly and discard expired medication properly
Avoid storing near heat sources or in very humid environments
Do not remove the desiccant (if present) from the bottle
"How quickly will I notice improvement?"
Most patients notice easier expectoration within 2-3 days
Full benefits for chronic conditions may take 1-2 weeks of regular use
Bronchodilator effects may be noticeable within hours of first dose
"Will this medication cure my condition?"
For chronic conditions like COPD, it manages symptoms but is not curative
In acute bronchitis, it helps speed recovery but doesn't replace antibiotics if needed
Regular use can help prevent complications and exacerbations
"Is this medication addictive?"
No, neither component has addictive properties
No evidence of physical or psychological dependence
Can be safely discontinued when no longer needed (though gradual reduction sometimes recommended)
"Can I take this with my other medications?"
Many medications can be taken with Broclear, but always inform your doctor
Specific timing may be important with certain antibiotics
Review all your medications with your healthcare provider or pharmacist
Most patients report improvement in cough productivity and ease of breathing, with manageable side effects. Gastrointestinal symptoms are the most commonly reported issues but tend to improve with continued use or taking the medication with food.
Take with food to minimize stomach upset
Drink plenty of fluids to enhance the mucolytic effect
Continue taking as prescribed even after feeling better
Be patient—mucolytic effects may take several days to become noticeable
Practice deep breathing and effective coughing techniques
Monitor for changes in color or consistency of expectorated mucus
Inform all healthcare providers about this medication
Keep a log of symptoms to discuss with your doctor
Never abruptly stop taking without medical advice
Store away from heat, moisture, and direct sunlight
Chemical Class
Acebrophylline: Xanthine derivative<br>Acetylcysteine: N-acetyl derivative of amino acid cysteine
Habit Forming
No
Therapeutic Class
Bronchodilator + Mucolytic
Action Class
Phosphodiesterase inhibitor + Mucolytic/Antioxidant agent
Before Starting Treatment:
Pulmonary function tests (spirometry)
Chest X-ray if not recently done
Complete blood count
Liver function tests
Kidney function tests
Sputum culture if infection suspected
ECG for patients with cardiac history
During Treatment:
Periodic spirometry to assess response
Liver function tests with extended use
Monitoring of sputum characteristics
Oxygen saturation measurements
Repeat chest imaging as clinically indicated
For more detailed information about Acebrophylline, Acetylcysteine, and Broclear Tablet, consult reliable medical sources such as:
British National Formulary (BNF)
Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines
Global Initiative for Asthma (GINA) guidelines
American Thoracic Society recommendations
European Respiratory Society publications
Your healthcare provider or pharmacist
Link to credible health sources:
This information is intended for educational purposes only and should not replace professional medical advice. Always consult your healthcare provider regarding any questions or concerns about your medical condition or treatment. Individual responses to medication can vary. Report any unusual or severe side effects to your healthcare provider immediately.